I remember when KM first announced the possibility of a new formulation. It was during the earnings call in January 2022, if my memory serves me right. And he said it would take three years to create. so the timing of a November announcement does seem to coincide with that projection. Originally, they spoke of using it in the United States and then, I thought, they began speaking of it as something that would only be released outside the United States, though I don't know why they changed their tune on that.